• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2420-0007
Device Problems Reflux within Device (1522); Insufficient Flow or Under Infusion (2182); Improper Flow or Infusion (2954)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/17/2018
Event Type  malfunction  
Manufacturer Narrative
Although requested, product has not been received.A follow up report will be submitted with failure investigation results should the device be received for evaluation.Requested patient demographics however customer decline to answer.
 
Event Description
The customer reported that a secondary non bd set was prepared for unspecified antibiotic infusion.The rn clamped the primary line to initiated the antibiotic however the rn noticed hat the secondary back flowed into the primary set.There was no patient harm however there was a delay in the medication in which patient required a new antibiotic and tubing set up.The event occurred in the icu.
 
Manufacturer Narrative
Concomitant medical products: 50ml baxter infusion bag (lot nc119924 exp 04apr20) of clindamycin in 0.9% nacl injection usp; 1000ml b braun infusion bag (lot j8n155 exp 04/21) of lactated ringers.The customer¿s report of secondary set back flowed into primary was not confirmed.Visual inspection of the set noted no damage or any anomalies.The check valve was inspected under magnification and was noted to be assembled in the set correctly, and the silicone membrane was centered.Functional testing resulted in no air bubbles or fluid going past the check valve or into the primary bag.Disassembly of the check valve resulted in normal findings.No particulates were noted on the diaphragm membrane or any solvent to the check valve component with no damages to the interior of the check valve or to the diaphragm.The root cause of this failure was not identified.
 
Event Description
The customer reported that a secondary non bd set was prepared for unspecified antibiotic infusion.The rn clamped the primary line to initiate the antibiotic however the rn noticed hat the secondary back flowed into the primary set.There was no patient harm however there was a delay in the medication in which patient required a new antibiotic and tubing set up.The event occurred in the icu.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8378613
MDR Text Key137426938
Report Number9616066-2019-00502
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203021012
UDI-Public7613203021012
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2420-0007
Device Catalogue Number2420-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/05/2019
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/28/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8015,8110,B BRAUN SEC LINE, THERAPY DATE (B)(6) 2018; NON-BD SECONDARY SET; 8015,8110,B BRAUN SEC LINE, THERAPY DATE (B)(6) 2018
-
-